Biotech · Private company
Can-Fite BioPharma
Track this companyFree. Adds Can-Fite BioPharma to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- CF101Phase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- NamodenosonPhase 3 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CF101Phase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- CF102Phase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisPHASE3 · RECRUITING · started Mar 15, 2023ClinicalTrials.gov NCT05201404 · fetched Nov 12, 2026
- Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)PHASE2 · COMPLETED · started Sep 1, 2014ClinicalTrials.gov NCT02128958 · fetched Nov 12, 2026
- Trial of CF101 to Treat Patients With PsoriasisPHASE2_PHASE3 · COMPLETED · started Jul 1, 2011ClinicalTrials.gov NCT01265667 · fetched Nov 12, 2026
- Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis PatientsPHASE2 · COMPLETED · started Jun 1, 2006ClinicalTrials.gov NCT00280917 · fetched Nov 12, 2026